ZA909512B - Transdermal flux enhancers in combination with iontophoresis in topical administration of pharmaceuticals - Google Patents
Transdermal flux enhancers in combination with iontophoresis in topical administration of pharmaceuticalsInfo
- Publication number
- ZA909512B ZA909512B ZA909512A ZA909512A ZA909512B ZA 909512 B ZA909512 B ZA 909512B ZA 909512 A ZA909512 A ZA 909512A ZA 909512 A ZA909512 A ZA 909512A ZA 909512 B ZA909512 B ZA 909512B
- Authority
- ZA
- South Africa
- Prior art keywords
- iontophoresis
- combination
- topical administration
- pharmaceuticals
- transdermal flux
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/443,699 US5023085A (en) | 1989-11-29 | 1989-11-29 | Transdermal flux enhancers in combination with iontophoresis in topical administration of pharmaceuticals |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA909512B true ZA909512B (en) | 1992-06-24 |
Family
ID=23761854
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA909512A ZA909512B (en) | 1989-11-29 | 1990-11-27 | Transdermal flux enhancers in combination with iontophoresis in topical administration of pharmaceuticals |
Country Status (17)
Country | Link |
---|---|
US (1) | US5023085A (xx) |
EP (1) | EP0435436B1 (xx) |
JP (1) | JPH0688912B2 (xx) |
KR (1) | KR930007248B1 (xx) |
AT (1) | ATE99961T1 (xx) |
AU (1) | AU613281B1 (xx) |
CA (1) | CA2030943A1 (xx) |
DE (1) | DE69006000T2 (xx) |
DK (1) | DK0435436T3 (xx) |
HU (1) | HUT55629A (xx) |
IE (1) | IE63597B1 (xx) |
IL (1) | IL96449A (xx) |
MY (1) | MY109727A (xx) |
NZ (1) | NZ236253A (xx) |
PH (1) | PH27105A (xx) |
PT (1) | PT96021B (xx) |
ZA (1) | ZA909512B (xx) |
Families Citing this family (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5196410A (en) * | 1986-10-31 | 1993-03-23 | Pfizer Inc. | Transdermal flux enhancing compositions |
EP0303713B2 (en) * | 1987-02-23 | 1997-07-30 | Shiseido Company Limited | Percutaneous absorption promoter and dermatologic preparation for external use |
US5080646A (en) * | 1988-10-03 | 1992-01-14 | Alza Corporation | Membrane for electrotransport transdermal drug delivery |
US5262165A (en) * | 1992-02-04 | 1993-11-16 | Schering Corporation | Transdermal nitroglycerin patch with penetration enhancers |
US5334138A (en) * | 1990-03-15 | 1994-08-02 | North Carolina State University | Method and composition for increased skin concentration of active agents by iontophoresis |
US5383848A (en) * | 1990-04-12 | 1995-01-24 | Gensia, Inc. | Iontophoretic administration of drugs |
US6223076B1 (en) | 1990-11-01 | 2001-04-24 | Robert Tapper | Sweat control system |
US6139537A (en) * | 1990-11-01 | 2000-10-31 | Tapper; Robert | Iontophoretic treatment system |
US6235013B1 (en) | 1990-11-01 | 2001-05-22 | Robert Tapper | Iontophoretic treatment system |
US5224927A (en) * | 1990-11-01 | 1993-07-06 | Robert Tapper | Iontophoretic treatment system |
US6582416B2 (en) | 1990-11-01 | 2003-06-24 | Robert Tapper | Iontophoretic treatment system |
US6600950B1 (en) * | 1990-11-01 | 2003-07-29 | Robert Tapper | Iontophoretic treatment system |
US6238381B1 (en) | 1990-11-01 | 2001-05-29 | Robert Tapper | Iontophoretic treatment system |
US6575957B1 (en) * | 1990-11-01 | 2003-06-10 | Robert Tapper | Iontophoretic treatment system |
US5131403A (en) * | 1991-06-05 | 1992-07-21 | Becton Dickinson And Company | Method for obtaining blood using iontophoresis |
US5356632A (en) * | 1991-09-12 | 1994-10-18 | S.I. Scientific Innovations Ltd. | Transdermal drug delivery device |
DE69320378T2 (de) * | 1992-01-21 | 1999-04-29 | Macrochem Corp | Iontophoretische verbesserte Verabreichung von Medikamenten |
JP3488466B2 (ja) * | 1992-06-02 | 2004-01-19 | アルザ・コーポレーション | 電気駆動式薬物投与デバイス |
US5580574A (en) * | 1994-04-28 | 1996-12-03 | Hoffmann-La Roche Inc. | Pharmaceutical composition for transdermal delivery |
US5594015A (en) * | 1994-06-22 | 1997-01-14 | Regents Of The University Of California | Thiazolidine derivatives for the treatment of psoriasis |
JP4090072B2 (ja) * | 1994-07-13 | 2008-05-28 | アルザ・コーポレーション | 経皮電気的移送式作用剤投与を促進するための組成物と方法 |
US5540654A (en) * | 1994-09-02 | 1996-07-30 | North Carolina State University | Iontophoretic electrode |
US5861439A (en) * | 1994-11-14 | 1999-01-19 | Alza Corporation | Method for enhanced electrotransport agent delivery |
US5736580A (en) * | 1994-11-14 | 1998-04-07 | Alza Croporation | Composition, device, and method for electrotransport agent delivery |
US5990179A (en) * | 1995-04-28 | 1999-11-23 | Alza Corporation | Composition and method of enhancing electrotransport agent delivery |
US5985316A (en) * | 1995-04-28 | 1999-11-16 | Alza Corporation | Composition and method of enhancing electrotransport agent delivery |
US6355025B1 (en) | 1995-06-07 | 2002-03-12 | Alza Corporation | Adjustable electrotransport drug delivery using a fixed output controller |
WO1997014473A1 (en) * | 1995-10-18 | 1997-04-24 | Novartis Ag | Thermopile powered transdermal drug delivery device |
US7094422B2 (en) | 1996-02-19 | 2006-08-22 | Acrux Dds Pty Ltd. | Topical delivery of antifungal agents |
AUPN814496A0 (en) | 1996-02-19 | 1996-03-14 | Monash University | Dermal penetration enhancer |
EP0849265A1 (de) * | 1996-12-20 | 1998-06-24 | HEUMANN PHARMA GmbH | Neue polymorphe Form von Doxazosin-Mesylat (Form II) |
AUPO907697A0 (en) * | 1997-09-09 | 1997-10-02 | Day, Robert Edward | Chemical supplementation of bone |
GB9723669D0 (en) * | 1997-11-07 | 1998-01-07 | Univ Aberdeen | Skin penetration enhancing components |
IL142808A0 (en) | 1998-11-02 | 2002-03-10 | Alza Corp | Electrotransport device including a compatible antimicrobial agent |
JP2001072592A (ja) | 1999-07-01 | 2001-03-21 | Kyowa Hakko Kogyo Co Ltd | テロメラーゼ阻害剤 |
CA2400325A1 (en) | 2000-02-18 | 2001-08-23 | University Of Utah Research Foundation | Methods for delivering agents using alternating current |
US6496728B2 (en) | 2000-02-18 | 2002-12-17 | University Of Utah Research Foundation | Methods for extracting substances using alternating current |
US6452014B1 (en) | 2000-12-22 | 2002-09-17 | Geron Corporation | Telomerase inhibitors and methods of their use |
US7137975B2 (en) * | 2001-02-13 | 2006-11-21 | Aciont, Inc. | Method for increasing the battery life of an alternating current iontophoresis device using a barrier-modifying agent |
MXPA03009121A (es) * | 2001-04-04 | 2004-11-22 | Johnson & Johnson | Dispositivo de suministro de electrotransporte transdermico que incluye una composicion de reserva compatible antimicrobiana. |
US7099713B2 (en) | 2002-06-28 | 2006-08-29 | Battelle Memorial Institute | Skin conduction and transport systems |
US20060116336A1 (en) * | 2004-03-17 | 2006-06-01 | American Pharmaceutical Partners, Inc. | Lyophilized azithromycin formulation |
US7468428B2 (en) * | 2004-03-17 | 2008-12-23 | App Pharmaceuticals, Llc | Lyophilized azithromycin formulation |
US20050220439A1 (en) * | 2004-03-19 | 2005-10-06 | Carton Owen A | Interactive multimedia system and method |
US20060222692A1 (en) * | 2005-03-31 | 2006-10-05 | Fairfield Clinical Trials Llc | Method and compositions for transdermal administration of antimicrobial medications |
WO2007004236A2 (en) * | 2005-07-04 | 2007-01-11 | Ramu Krishnan | Improved drug or pharmaceutical compounds and a preparation thereof |
WO2007147043A2 (en) * | 2006-06-16 | 2007-12-21 | Transport Pharmaceutical, Inc. | Pharmaceutical formulations for iontophoretic tetracycline antibiotic delivery |
WO2009158477A1 (en) | 2008-06-25 | 2009-12-30 | Us Worldmeds Llc | Skin patches and sustained-release formulations comprising lofexidine for transdermal and oral delivery |
WO2010054356A1 (en) * | 2008-11-10 | 2010-05-14 | Nitric Biotherapeutics, Inc. | Pharmaceutical formulations for iontophoretic delivery of a corticosteroid |
US20100331812A1 (en) * | 2009-06-29 | 2010-12-30 | Nitric Biotherapeutics, Inc. | Pharmaceutical Formulations for Iontophoretic Delivery of an Immunomodulator |
US11607407B2 (en) | 2010-04-13 | 2023-03-21 | Relmada Therapeutics, Inc. | Dermal pharmaceutical compositions of 1-methyl-2′,6′-pipecoloxylidide and method of use |
US10272097B2 (en) | 2013-12-24 | 2019-04-30 | Virginia Commonwealth University | Uses of oxygenated cholesterol sulfates (OCS) |
WO2019074870A1 (en) * | 2017-10-09 | 2019-04-18 | The Broad Institute, Inc. | COMPOSITIONS AND METHODS FOR DISCOVERING COMBINATORY DRUG IN DROPLETS OF THE NANOLITRE ORDER |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3991755A (en) * | 1973-07-27 | 1976-11-16 | Medicon, Inc. | Iontophoresis apparatus for applying local anesthetics |
US4316893A (en) * | 1975-06-19 | 1982-02-23 | Nelson Research & Development Co. | Vehicle composition containing 1-substituted azacycloalkan-2-ones |
US3989816A (en) * | 1975-06-19 | 1976-11-02 | Nelson Research & Development Company | Vehicle composition containing 1-substituted azacycloheptan-2-ones |
US4405616A (en) * | 1975-06-19 | 1983-09-20 | Nelson Research & Development Company | Penetration enhancers for transdermal drug delivery of systemic agents |
US4954487A (en) * | 1979-01-08 | 1990-09-04 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions |
JPS6036299B2 (ja) * | 1981-07-02 | 1985-08-20 | タカラベルモント株式会社 | イオン導入器 |
HU185691B (en) * | 1982-02-09 | 1985-03-28 | Richter Gedeon Vegyeszet | Process for preparing a new analgetic pharmaceutical composition |
US4557934A (en) * | 1983-06-21 | 1985-12-10 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one |
US4919648A (en) * | 1983-08-18 | 1990-04-24 | Drug Delivery Systems Inc. | High tack drug patch |
JPS6222662A (ja) * | 1985-07-19 | 1987-01-30 | 林原 健 | イオン導入電子治療器 |
MY102980A (en) * | 1986-10-31 | 1993-03-31 | Pfizer | Transdermal flux enhancing compositions |
US5108363A (en) * | 1988-02-19 | 1992-04-28 | Gensia Pharmaceuticals, Inc. | Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist |
CA1331137C (en) * | 1988-02-29 | 1994-08-02 | Pfizer, Inc. | Transdermal flux enhancing compositions |
-
1989
- 1989-11-29 US US07/443,699 patent/US5023085A/en not_active Expired - Fee Related
-
1990
- 1990-11-02 PH PH41182A patent/PH27105A/en unknown
- 1990-11-08 DE DE90312217T patent/DE69006000T2/de not_active Expired - Fee Related
- 1990-11-08 DK DK90312217.4T patent/DK0435436T3/da active
- 1990-11-08 AT AT90312217T patent/ATE99961T1/de not_active IP Right Cessation
- 1990-11-08 EP EP90312217A patent/EP0435436B1/en not_active Expired - Lifetime
- 1990-11-22 IL IL9644990A patent/IL96449A/en not_active IP Right Cessation
- 1990-11-27 MY MYPI90002098A patent/MY109727A/en unknown
- 1990-11-27 ZA ZA909512A patent/ZA909512B/xx unknown
- 1990-11-27 CA CA002030943A patent/CA2030943A1/en not_active Abandoned
- 1990-11-28 PT PT96021A patent/PT96021B/pt not_active IP Right Cessation
- 1990-11-28 HU HU907681A patent/HUT55629A/hu unknown
- 1990-11-28 NZ NZ236253A patent/NZ236253A/xx unknown
- 1990-11-28 KR KR1019900019334A patent/KR930007248B1/ko not_active IP Right Cessation
- 1990-11-28 AU AU67069/90A patent/AU613281B1/en not_active Ceased
- 1990-11-28 IE IE428190A patent/IE63597B1/en not_active IP Right Cessation
- 1990-11-29 JP JP2333509A patent/JPH0688912B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
IE904281A1 (en) | 1991-06-05 |
IL96449A (en) | 1996-07-23 |
ATE99961T1 (de) | 1994-01-15 |
KR910009250A (ko) | 1991-06-28 |
KR930007248B1 (ko) | 1993-08-04 |
DE69006000D1 (de) | 1994-02-24 |
AU613281B1 (en) | 1991-07-25 |
HUT55629A (en) | 1991-06-28 |
EP0435436B1 (en) | 1994-01-12 |
JPH0688912B2 (ja) | 1994-11-09 |
PH27105A (en) | 1993-03-16 |
CA2030943A1 (en) | 1991-05-30 |
US5023085A (en) | 1991-06-11 |
PT96021A (pt) | 1991-09-13 |
EP0435436A2 (en) | 1991-07-03 |
EP0435436A3 (en) | 1992-01-08 |
IE63597B1 (en) | 1995-05-17 |
JPH03176426A (ja) | 1991-07-31 |
PT96021B (pt) | 1998-02-27 |
NZ236253A (en) | 1993-05-26 |
DK0435436T3 (da) | 1994-02-28 |
DE69006000T2 (de) | 1994-05-05 |
MY109727A (en) | 1997-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA909512B (en) | Transdermal flux enhancers in combination with iontophoresis in topical administration of pharmaceuticals | |
AU576724B2 (en) | Transdermally delivering nitroglycerine | |
ATE86870T1 (de) | Transdermales verabreichungssystem. | |
DE3751761D1 (de) | Penetrationsverbesserer für die transdermale Verabreichung von systemisch wirksamen Arzneimitteln | |
NO307644B1 (no) | Transdermalt, terapeutisk system med krystalliseringsinhibitor | |
GR871197B (en) | Pharmaceutical composition with analgesic activity | |
ATE67185T1 (de) | Substituierte oxindol-3-carboxamine als entzuendungshemmendes und schmerzstillendes mittel. | |
GB2278056B (en) | Thioglycolic and mercaptopropanoic acid derivatives as topical penetration enhancers | |
AU6125386A (en) | Methods and compositions useful in preventing equine influenza | |
ZA865019B (en) | 1-substituted oxindole-3-carboxamides as antiinflammatory and analgesic agents | |
ATE140703T1 (de) | Diaminsalze von clavulansäure | |
DE3863200D1 (de) | In der krebstherapie verwendbare zusammensetzung auf der basis von aminosaeure und vitaminen. | |
DK131586A (da) | Transdermalt, antiallergisk, farmaceutisk praeparat | |
FR2566662B1 (fr) | Association medicamenteuse utilisee en photochimiotherapie | |
ZM1185A1 (en) | 3-substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents | |
AU6658686A (en) | N-(5-tetrazolyl) pyrazine-2-carboxamides and their use as anti-allergic agents | |
ES8704903A1 (es) | Un metodo para preparar 6-cloro-2-metil-1h-2,3,4,5-tetrahidro-3-benzazepen-n-oxido. | |
PH23435A (en) | Benzamide and application thereof in the therapeutic field | |
DK222988D0 (da) | Farmaceutiske praeparater indeholdende ornithin-decarboxylase-inhibitorer | |
ATE65396T1 (de) | Verwendung von carbonsaeure in fuer topische anwendung vorgesehenen pharmazeutischen zubereitungen. | |
DE3777411D1 (de) | Mittel zur verbesserung der perkutanen verabreichung von arzneimitteln. | |
AP8500009A0 (en) | New phenoxypropanolamine salts and pharmaceutical preparations thereof. | |
NZ211052A (en) | 1,3-disubstituted-2-oxindoles as analgesic and anti-inflammatory agents | |
PL332035A1 (en) | Transdermal therapeutic system including an estriol-containing composition of active substances | |
ATE94197T1 (de) | Eindringungserhoehende mittel zur transdermalen verabreichung systemischer mittel. |